SBIR-STTR Award

Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity
Award last edited on: 4/18/19

Sponsored Program
STTR
Awarding Agency
NIH : NIGMS
Total Award Amount
$254,431
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Shih-Yuan Liu

Company Information

Quintessence Chemicals LLC (AKA: QE Chemicals, Inc)

84851 Mcbeth Road
Eugene, OR 97405
   (541) 913-3921
   N/A
   N/A

Research Institution

University of Oregon

Phase I

Contract Number: 1R41GM099181-01
Start Date: 9/26/11    Completed: 9/25/12
Phase I year
2011
Phase I Amount
$254,431
Overdose on acetaminophen (more commonly known by the brand name Tylenol(R)), accounts for 56,000 emergency room visits and more than 450 deaths annually in the USA. Acetaminophen overdose can occur by a single event of exceeding the recommended daily dosage. Overdose on acetaminophen is facilitated by the fact that it is a common ingredient in over-the-counter medications for cold, allergies, and congestion, conditions for which people often take multiple medications. The hepatotoxicity of acetaminophen is due to N-acetyl-p- benzoquinoneimine (NAPQI), which is generated by oxidative metabolism. Proposed herein are new 1,2-azaborines, wherein a CC bond pair of an arene is replaced with an isosteric boron- nitrogen unit that is designed to eliminate the formation of the toxic metabolite. This proposal seeks to: 1) synthesize novel 1,2-azaborine-based derivatives of acetaminophen, 2) determine their cytotoxicity and pharmacokinetics via appropriate in vitro tests, and 3) identify compounds to be studied in a Phase II STTR application.

Public Health Relevance:
Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity Overdose on acetaminophen (more commonly known by the brand name Tylenol(R)), accounts for 56,000 emergency room visits and more than 450 deaths annually in the USA. The toxicity of acetaminophen to the liver is due to a metabolic by-product. Proposed herein are new boron-nitrogen-containing analogues of acetaminophen that are designed to eliminate the formation of that metabolic by-product.

Thesaurus Terms:
Apap;Apap Overdose;Accident And Emergency Department;Accounting;Acetamide, N-(4-Ethoxyphenyl)-;Acetamide, N-(4-Hydroxyphenyl)-;Acetamidophenol;Acetaminophen;Acetominophen;Acetophenetidin;Acute Hepatic Failure;Acute Liver Failure;Allergy;B Element;Biological;Biological Testing;Boron;Cell Respiration;Cellular Respiration;Cessation Of Life;Death;Dose;Drug Kinetics;Drug Usage;Drugs;Emergency Department;Emergency Room;Evaluation;Event;Exhibits;Fever;Fulminant Liver Failure;Fulminating Hepatic Failure;Fulminating Liver Failure;Goals;Hepatic Failure;Hepatotoxic Effect;Hepatotoxicity;Human Cell Line;Hydroxyacetanilide;Hypersensitivity;Hyperthermia;In Vitro;Investigation;Loinc Axis 2 Property;Liver;Liver Failure;Liver Toxicity;Lytotoxicity;Medication;Metabolic;Methods;N Element;N-(4-Hydroxyphenyl)Acetanilide;N-Acetyl-P-Aminophenol;N-Acetyl-4-Benzoquinone Imine;N-Acetyl-4-Benzoquinoneimine;N-Acetyl-P-Benzoquinoneimine;N2 Element;Nabq;Napqi;Names;Nitrogen;Overdose;Pain;Painful;Pair Bond;Paracetamol;Pharmaceutic Preparations;Pharmaceutical Preparations;Pharmacokinetics;Phase;Phenacetin;Poisoning;Property;Pyrexia;Sttr;Schedule;Scheme;Small Business Technology Transfer Research;Task Performances;Therapeutic Index;Toxic Effect;Toxic Effect On Liver Cells;Toxicities;Tylenol;Visit;Acetaminophen Overdose;Aerobic Metabolism;Aerobic Respiration;Analog;Base;Cytotoxic;Cytotoxicity;Design;Designing;Dosage;Drug Candidate;Drug Use;Drug/Agent;Experiment;Experimental Research;Experimental Study;Febrile;Febris;Fulminant Hepatic Failure;Hepatic Body System;Hepatic Organ System;Hepatoxicity;In Vitro Testing;Novel;Oxidative Metabolism;P-Acetamidophenol;P-Hydroxyacetanilide;Paracetamol Overdose;Phase 2 Study;Phase Ii Study;Poisoned;Research Study

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----